# Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

> **NCT07300059** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Aspargo Labs, Inc** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Liquid Metformin 100 mg/mL
- **DRUG:** Liquid Metformin 250 mg/mL
- **DRUG:** Standard Metformin Immediate-Release Tablet

## Key facts

- **NCT ID:** NCT07300059
- **Lead sponsor:** Aspargo Labs, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2026-08-15
- **Final completion:** 2026-08-28
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300059, "Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07300059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*